Eugene Mannheimer

Stock Analyst at Freedom Capital Markets

(3.81)
# 1,970
Out of 5,090 analysts
73
Total ratings
50.5%
Success rate
7.5%
Average return

Stocks Rated by Eugene Mannheimer

HealthStream
Oct 14, 2026
Initiated: Hold
Price Target: $36
Current: $33.75
Upside: +6.67%
Astrana Health
Oct 1, 2026
Reiterated: Buy
Price Target: $50
Current: $37.87
Upside: +32.03%
Nutex Health
Sep 25, 2026
Reiterated: Buy
Price Target: $56 → $306
Current: $204.36
Upside: +49.74%
Omada Health
Sep 14, 2026
Reiterated: Buy
Price Target: $35
Current: $18.30
Upside: +91.26%
Doximity
Sep 8, 2026
Downgraded: Hold
Price Target: $31 → $27
Current: $30.55
Upside: -11.62%
Phreesia
Sep 3, 2026
Reiterated: Buy
Price Target: $14
Current: $10.75
Upside: +30.23%
Tempus AI
Aug 31, 2026
Reiterated: Hold
Price Target: $59 → $73
Current: $68.22
Upside: +7.01%
HeartFlow
Aug 27, 2026
Reiterated: Buy
Price Target: $44
Current: $50.32
Upside: -12.56%
iRhythm Holdings
Aug 20, 2026
Reiterated: Buy
Price Target: $205 → $190
Current: $107.71
Upside: +76.40%
Consensus Cloud Solutions
Aug 18, 2026
Reiterated: Buy
Price Target: $38 → $44
Current: $37.54
Upside: +17.21%
Reiterated: Buy
Price Target: $59 → $103
Current: $105.14
Upside: -2.04%
Reiterated: Buy
Price Target: $52 → $60
Current: $36.45
Upside: +64.61%
Initiated Coverage: Hold
Price Target: $40
Current: $26.30
Upside: +52.09%
Reiterated: Buy
Price Target: $10 → $8
Current: $3.24
Upside: n/a
Reiterated: Buy
Price Target: $14 → $13
Current: $0.0001
Upside: n/a
Reiterated: Buy
Price Target: $13 → $12
Current: $1.95
Upside: n/a
Reiterated: Buy
Price Target: $46 → $42
Current: $0.0001
Upside: n/a
Reiterated: Buy
Price Target: $18
Current: $5.00
Upside: n/a
Downgraded: Hold
Price Target: $80 → $98
Current: $961.88
Upside: n/a
Reiterated: Buy
Price Target: $24
Current: $9.15
Upside: n/a